Mathers Edward T. - 07 Mar 2025 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SNTI	Stock Option (Right to Buy)	Award	$0	+43,900		$0.000000	43,900	07 Mar 2025	Common Stock	43,900	$3.52	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	100% of the shares underlying this option vest on the first anniversary of the date of grant, subject to the reporting person's continued service through the applicable vesting date.